Castle Biosciences to Present at the 2026 Jefferies Global Healthcare Conference

About this update from Castle Biosciences, Inc.

[{"type":"text","content":"FRIENDSWOOD, Texas, May 13, 2026 /PRNewswire/ -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management is scheduled to present a company overview at the 2026 Jefferies Global Healthcare Conference on Wednesday, June 3, 2026, at 1:20 p.m. Eastern time.","length":371,"tagName":"p"},{"type":"image","alt":"Castle Biosciences (PRNewsfoto/Castle Biosciences, Inc.)","displaySize":"","headline":null,"caption":"Castle Biosciences (PRNewsfoto/Castle Biosciences, Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":117,"url":"https://media.zenfs.com/en/prnewswire.com/d6f680556e1a27581fb6f9c8010c7733"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/xFUx4NTeRDZ.0tnWjn48Tw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTIwNg--/https://media.zenfs.com/en/prnewswire.com/d6f680556e1a27581fb6f9c8010c7733","width":400,"height":117},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/vZCxSsODHOZ0bGplRCc56g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTE4Nw--/https://media.zenfs.com/en/prnewswire.com/d6f680556e1a27581fb6f9c8010c7733","width":400,"height":117}},"href":"https://mma.prnewswire.com/media/2942411/Castle_Biosciences_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"A live audio webcast of the Company's presentation will be available by visiting Castle Biosciences' website or at this link. A replay of the webcast will be available following the conclusion of the live broadcast.","length":223,"tagName":"p"},{"type":"text","content":"About Castle BiosciencesCastle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. With a primary focus in dermatologic and gastroenterological disease, we develop personalized, clinically actionable solutions that help improve disease management and patient outcomes.","length":344,"tagName":"p"},{"type":"text","content":"We put people first—empowering patients and clinicians and informing care decisions through rigorous science and advanced molecular tests that support more confident treatment planning. To learn more, visit www.CastleBiosciences.com and connect with us on LinkedIn, Facebook, X and Instagram.","length":297,"tagName":"p"},{"type":"text","content...

More updates from Castle Biosciences, Inc.